Bliss GVS Pharma's Stock Sees Significant Increase, Outperforms Sector and Sensex

Bliss GVS Pharma, a smallcap pharmaceutical company, has seen a significant increase in its stock price on August 21, 2024. The stock has gained 8.57% and is currently trading at Rs. 126.05 per share. MarketsMOJO, a leading stock analysis platform, has given a 'Hold' call for the stock.

According to MarketsMOJO, Bliss GVS Pharma has been a part of their Hidden Turnaround list since November 2, 2023. This indicates that the company has shown signs of improvement and has potential for growth in the future.

In terms of performance, Bliss GVS Pharma has outperformed the sector by 6.14% on August 21. The stock has been on a consecutive gain for the last 3 days and has seen a rise of 15.83% during this period. It also touched an intraday high of Rs. 128.05, showing a 7.02% increase.

Bliss GVS Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance.

On a comparative basis, Bliss GVS Pharma has performed better than the Sensex on both a 1-day and 1-month basis. On August 21, the stock's performance was 8.23% compared to Sensex's -0.11%. In the last month, Bliss GVS Pharma has seen a 17.57% increase while the Sensex has only seen a 0.14% increase.

Overall, Bliss GVS Pharma's stock has shown a positive trend and has outperformed the sector and the Sensex. MarketsMOJO's 'Hold' call suggests that investors should hold onto their current positions in the stock.